Evidence map›Paper›PMID 24613985›Full record

ReviewCurrent opinion in psychiatry2014

Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?

Jeanne E Maglione, Scot E Thomas, Dilip V Jeste

Abstract readReview
In one paragraph

Review in Current opinion in psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Vascular Schizophrenia-like Psychosis in Older Adults.Journal of clinical medicine · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Clinical Approaches to Late-Onset Psychosis.Journal of personalized medicine · 2022
    Review
  11. Polygenic Risk Scores for Subtyping of Schizophrenia.Schizophrenia research and treatment · 2020
    Article
  12. Article
  13. Cognitive Functioning in Older Adults With Schizophrenia.Focus (American Psychiatric Publishing) · 2017
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeanne E MaglioneDepartment of Psychiatry, University of California, San Diego, La Jolla, California, USA.
Scot E Thomas
Dilip V Jeste
University of California, San Diego · USInstitute on Aging · US

Funding

SAN DIEGO CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTEUL1RR031980 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2010 to 2011
$14.0M
Research Methods CoreP30MH080002 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JESTE, DILIP V. · 2007 to 2011
$9.6M
FELLOWSHIP IN GERIATRIC MENTAL HEALTHT32MH019934 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Elizabeth W Twamley · 1994 to 2026
$9.5M
Accelerated Inflammaging in SchizophreniaR01MH094151 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EYLER, LISA T · 2012 to 2021
$7.4M
NCRR NIH HHS UL1 RR031980NCRR NIH HHS UL1RR031980.NIMH NIH HHS P30 MH080002NIMH NIH HHS R01 MH094151NIMH NIH HHS T32 MH019934NIMH NIH HHS T32 MH019934-18
6 · The paper itself

Abstract

purpose or reviewTo review recent literature about late-onset schizophrenia (LOS): schizophrenia with onset between ages 40 and 60 years. New findings are presented in the context of the previous literature. RECENT

findingsNewer studies continue to suggest that early-onset schizophrenia (EOS) and LOS share fundamental clinical features (i.e., positive symptoms, negative symptoms, functional deficits). One larger recent study confirmed earlier findings that LOS differs from EOS in several important ways, including predominance of women, lower severity of positive symptoms, and lower average antipsychotic dose requirement. However, this study did not find LOS patients were more likely to have the paranoid subtype or to have less severe negative symptoms compared with EOS patients. New neuroimaging and molecular studies are identifying possible differences in the underlying pathophysiology of EOS and schizophrenia developing in mid-life to late-life; however, more research is needed to confirm these findings and determine their significance. No studies evaluated treatment strategies specifically in LOS. SUMMARY: LOS continues to be an understudied area. Recent studies add support to the idea that LOS may be a distinct subtype of schizophrenia. Studies designed to elucidate the pathophysiology of LOS in comparison with EOS and to assess treatment strategies in this population are needed.

Indexed as

AdultAge of OnsetAntipsychotic AgentsHumansMiddle AgedSchizophreniaSchizophrenic PsychologyAntipsychotic Agents

Identifiers

PMID24613985
PMCPMC4418466
OpenAlexW2007437170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.